VOYA Investment Management’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-22,480
| Closed | -$116K | – | 2601 |
|
|
2019
Q2 | $116K | Buy |
22,480
+2,950
| +15% | +$13.3K | ﹤0.01% | 2432 |
|
|
2019
Q1 | $70K | Hold |
19,530
| – | – | ﹤0.01% | 2487 |
|
|
2018
Q4 | $120K | Hold |
19,530
| – | – | ﹤0.01% | 2363 |
|
|
2018
Q3 | $114K | Hold |
19,530
| – | – | ﹤0.01% | 2480 |
|
|
2018
Q2 | $83K | Hold |
19,530
| – | – | ﹤0.01% | 2548 |
|
|
2018
Q1 | $86K | Hold |
19,530
| – | – | ﹤0.01% | 2498 |
|
|
2017
Q4 | $103K | Hold |
19,530
| – | – | ﹤0.01% | 2497 |
|
|
2017
Q3 | $120K | Hold |
19,530
| – | – | ﹤0.01% | 2514 |
|
|
2017
Q2 | $141K | Buy |
19,530
+3,610
| +23% | +$22.2K | ﹤0.01% | 2500 |
|
|
2017
Q1 | $84K | Hold |
15,920
| – | – | ﹤0.01% | 2449 |
|
|
2016
Q4 | $114K | Hold |
15,920
| – | – | ﹤0.01% | 2430 |
|
|
2016
Q3 | $149 | Hold |
15,920
| – | – | ﹤0.01% | 2397 |
|
|
2016
Q2 | $101K | Hold |
15,920
| – | – | ﹤0.01% | 2471 |
|
|
2016
Q1 | $88K | Hold |
15,920
| – | – | ﹤0.01% | 2424 |
|
|
2015
Q4 | $89K | Hold |
15,920
| – | – | ﹤0.01% | 2497 |
|
|
2015
Q3 | $135K | Hold |
15,920
| – | – | ﹤0.01% | 2411 |
|
|
2015
Q2 | $241K | Hold |
15,920
| – | – | ﹤0.01% | 2399 |
|
|
2015
Q1 | $255K | Hold |
15,920
| – | – | ﹤0.01% | 2332 |
|
|
2014
Q4 | $284K | Hold |
15,920
| – | – | ﹤0.01% | 2309 |
|
|
2014
Q3 | $160K | Hold |
15,920
| – | – | ﹤0.01% | 2546 |
|
|
2014
Q2 | $249K | Buy |
+15,920
| New | +$226K | ﹤0.01% | 2448 |
|
Other funds holding PETX
VOYA Investment Management's PETX Position: Q3 2019 in Review
VOYA Investment Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 22,480 shares — an estimated $116K sold.
VOYA Investment Management first reported a position in PETX in Q2 2014 and held it in 21 quarters. The position peaked at $284K in Q4 2014. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- VOYA Investment Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- VOYA Investment Management sold 22,480 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $116K.
- VOYA Investment Management first reported a position in Aratana Therapeutics, Inc. in Q2 2014 and held it in 21 quarters.
- VOYA Investment Management's Aratana Therapeutics, Inc. position peaked at $284K in Q4 2014.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on VOYA Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.